2Derelle J, Bertolo HE, Marchal F, et al. Respiratory evolution of patient with mucoviscidosis treatedwith rnucolytic agents plus domasealfa [J]. Arch Pediatr, 1998, 5(4) :517-522.
3Kupczyk M, Kuna P. Mucolytics in acut/ and chronicrespiratory tract disorders . Ⅰ. Pathophysiology and mechanisms of action [J]. Pol Merkuriusz Lek, 2002,12 (69) :245-247.
4Kupczyk M, Kuna P. Mucolytics in acute and chronicrespiratory tract disorders. Ⅱ. Uses for treatment and antioxidant properties [J]. Pol Merkuriusz Lek, 2002, 12(69) : 248-252.
